Related Experiment Video
Updated: Jun 28, 2025

Thermostabilization, Expression, Purification, and Crystallization of the Human Serotonin Transporter Bound to S-citalopram
Published on: November 27, 2016
Long COVID-19 and Peripheral Serotonin: A Commentary and Reconsideration
George M Anderson1,2, Edwin H Cook3, Randy D Blakely4
1Yale Child Study Center, Yale University School of Medicine, New Haven, CT, USA.
Critique of a study on serotonin reduction in long COVID suggests flawed methodology. The reported plasma serotonin levels are likely inaccurate due to platelet depletion, invalidating conclusions about viral infection and SSRI treatments.
Area of Science:
- Biochemistry
- Virology
- Pharmacology
Background:
- A recent paper, "Serotonin reduction in post-acute sequelae of viral infection," reported significant findings.
- The paper suggested a link between reduced serotonin and long COVID, proposing selective serotonin reuptake inhibitors (SSRIs) as a treatment.
- Concerns exist regarding the methodology and interpretation of results in the original study.
Purpose of the Study:
- To critically evaluate the methodology and conclusions of a published paper on serotonin levels in viral infections and long COVID.
- To address potential inaccuracies in reported plasma serotonin concentrations.
- To re-evaluate the proposed link between serotonin and long COVID sequelae, including cardiovascular issues.
Main Methods:
- Analysis of the blood centrifugation procedure described by Wong et al.
- Assessment of the impact of platelet depletion on reported plasma serotonin concentrations.
- Review of the data presented regarding SSRI treatment and serotonin restoration.
Main Results:
- The centrifugation method likely results in over 95% platelet depletion, rendering reported plasma serotonin levels significantly overestimated (30-60 times too high).
- Reported plasma serotonin values for control, long COVID, and viremia groups are deemed unreliable and should be disregarded.
- No data were presented to support claims of serotonin restoration with SSRI administration; SSRIs are expected to decrease platelet serotonin.
Conclusions:
- The original study's findings and conclusions regarding serotonin reduction in viral infections and long COVID are invalidated by methodological flaws.
- The proposed use of SSRIs for long COVID treatment based on this study is not supported by the presented evidence.
- Reduced platelet serotonin, rather than peripheral serotonin, may be more relevant to long COVID, potentially mitigating cardiovascular sequelae due to decreased platelet aggregation.
More Related Videos
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
08:49Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
Published on: September 23, 2015
Related Concept Videos
Social Anxiety Disorder
G-protein Coupled Receptors
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
Antidepressant Drugs: MAOIs and Other Agents
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Stress and Mental Health
Individuals with depression often experience challenges in both their personal and professional...